Ora

As Hurricane Milton approaches Florida, our thoughts are with everyone in the storm’s path, including our employees, their families, our site partners, and the communities we serve. At Ora, putting people first is more than a belief, it is a commitment. And in moments like these, we are reminded of the strength that comes from standing together, supporting one another, and finding hope amid uncertainty.    To everyone in the impacted areas, stay safe, reach out, and let’s continue to support one another.   For those looking to support ongoing relief efforts, the Red Cross provides information on how to help those affected by Hurricane Milton and those still recovering from Hurricane Helene in North Carolina. Link to Red Cross Hurricane Relief: https://rdcrss.org/4gScVzT

Ophthalmology clinical trials require a level of expertise and precision that few CROs can provide. With George Ousler, one of the world’s leading experts in dry eye disease, and Dr. Gus de Moraes, a global authority in glaucoma, Ora brings unrivaled clinical knowledge to every trial. 🧬 They’re just two of the many world-class experts leading Ora’s efforts to ensure clinical trial success. Our team of seasoned professionals, including specialists in areas like retinal disease, corneal disorders, and glaucoma, is at the forefront of ophthalmic innovation. Their collective experience has been instrumental in 85+ product approvals and over 3,000 clinical trials completed. Looking for an expert partner who understands the complexities of ophthalmology research? Let’s connect at AAO or visit us at https://hubs.la/Q02SbnYS0 #ora #ophthalmology #aao2024 #CRO #clinicaltrials

With over 85+ product approvals and 3,000+ clinical trials completed, Ora has a proven track record of success in the ophthalmology field. We partner with sponsors to accelerate drug and device development, offering unmatched expertise and innovative solutions at every stage of the clinical process. Here’s how we do it: ✔️Deep therapeutic expertise in ophthalmology. ✔️Streamlined patient recruitment. ✔️Innovative trial design & endpoints. ✔️Global regulatory expertise. Partner with Ora to speed up your clinical programs while maintaining the highest quality standards. Learn more at https://hubs.la/Q02S9YsN0 #ora #ophthalmology #CRO #clinicaltrials

Two weeks until the world of ophthalmology convenes in the windy city for AAO 2024! 🗓️ Ora is proud to lead the field in ophthalmic clinical trials, delivering faster results and deeper insights. Our proven expertise in drug and device development ensures precision and efficiency at every phase. 🧬 Want to know how Ora’s innovative solutions can accelerate your clinical program? Let's meet at AAO! #ora #ophthalmology #aao #aao2024 #CRO

As part of our ongoing Blind Canvas Project series, we’re showcasing the experiences of the blind and low-vision community through their artwork. This image visualizes a conversation between Raquel and her younger self about her diagnosis of retinitis pigmentosa. The artwork represents a meaningful exchange of wisdom and support, with the background symbolizing the broad range of opportunities available despite vision loss. “If I were able to sit down with my 12-year-old self, I would show her the art and achievements of other visually impaired people. I’d share their music, photography, and other talents to inspire her and show her the many possibilities available.” To learn more about Raquel’s journey, visit her profile on the Blind Canvas Project website: https://hubs.la/Q02MT76l0 #ora #blindcanvasproject #ai #blindcan #ophthalmology

Raquel Alim was diagnosed with retinitis pigmentosa when she was 12 years old, and since then has embarked on an inspirational journey of self-discovery. Raquel found a love for art and architecture at a young age but felt incapable of pursuing these endeavors once her blindness began to intensify. After years of isolation and despair, she finally found hope within a community of other visually-impaired individuals, and returned to her love of art. She now uses art as a way to spread awareness and provide faith for others who might feel lost. To learn more about Raquel and her story, visit her profile on the Blind Canvas Project Website: https://hubs.la/Q02MTtDx0 #ora #blindcanvasproject #ai #blindcan #ophthalmology

We are thrilled to announce that Nicox and its partner in China, Ocumension Therapeutics have received approval for Zerviate in China for the treatment of allergic conjunctivitis! This significant milestone underscores the collaborative efforts in advancing eye care solutions. At Ora, we played a key role in this achievement by providing our validated Ora Calibra allergy scales and conducting comprehensive investigator training. These contributions were vital in the successful submission process for Zerviate, building on our previous work with Aciex and Nicox in the U.S. We are proud to have supported Nicox and Ocumension Therapeutics in their journey and look forward to seeing the positive impact of Zerviate for patients suffering from allergic conjunctivitis. For more details, check out the full announcement here: https://hubs.la/Q02Q-zCt0 Congratulations to everyone involved in this journey! 恭喜大家!

What an fantastic event for a great cause! Ora is excited to have been a part of The Eye Ball 2024 and to see the community come together in support of VisionSave and the incredible work Singapore National Eye Centre is doing to advance eye care. #Grateful #Ora #Ophthalmology #CRO

As part of our ongoing Blind Canvas Project series, we continue to showcase the unique experiences of the blind and low-vision community through their artwork. This image reflects Alayna’s fear of the unpredictability in navigating her diagnosis. She struggles with fitting into a single identity, uncertain of who she is supposed to be now that she is perceived as “different.” As Alayna shares, “I had to throw away my whole life. I had to throw away who I was because I had this incorrect perception of what a blind person was and what they should act like. I felt stuck on this roller coaster of different emotions throughout that year.” To learn more about Alayna’s journey, visit her profile on the Blind Canvas Project website: https://hubs.la/Q02MT5Ws0 #ora #blindcanvasproject #ai #blindcan #ophthalmology

We’re back in Barcelona for the Retina Forum, once again at the stunning Esferic venue, following our recent participation in the European forum just a couple of weeks ago. This morning, our Retina Therapeutic Area Head, Keith Lane, participated in a valuable panel discussion on "The Impact of Extended Duration with Injections on Novel Drug Delivery Approaches for Posterior Segment Diseases." The session sparked engaging conversations on the future of retinal therapies, highlighting the importance of innovative solutions to improve patient outcomes and reduce treatment burden. We were excited to share insights on advancing retinal treatments and exploring innovative approaches to drug delivery for posterior segment diseases! #RetinaForum #Ophthalmology #ClinicalTrials #Ora #Innovation #Retina #DrugDelivery